In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer

In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer have?

In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer has 110 citations in the OpenAlex counts ScholarIQ stores.

When was In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer published?

In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer has 2017 year in the ScholarIQ index.

What is the open-access status of In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer?

In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer has bronze oa status in the ScholarIQ index.

What is the DOI of In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer?

The DOI for In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer is on the source record.

What is the PMID of In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer?

The PMID for In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer is on the source record.

What is the OpenAlex record for In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer?

The OpenAlex for In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer is on the source record.